Lasker v. UBS SECURITIES LLC

614 F. Supp. 2d 345, 2008 U.S. Dist. LEXIS 35462, 2008 WL 1968737
CourtDistrict Court, E.D. New York
DecidedApril 30, 2008
DocketCV-08-0854 (CPS)(RER)
StatusPublished
Cited by4 cases

This text of 614 F. Supp. 2d 345 (Lasker v. UBS SECURITIES LLC) is published on Counsel Stack Legal Research, covering District Court, E.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Lasker v. UBS SECURITIES LLC, 614 F. Supp. 2d 345, 2008 U.S. Dist. LEXIS 35462, 2008 WL 1968737 (E.D.N.Y. 2008).

Opinion

MEMORANDUM OPINION AND ORDER

SIFTON, Senior District Judge.

Howard Lasker (“plaintiff’), on behalf of himself and others similarly situated, filed this purported class action against UBS Loan Finance LLC and UBS Securities LLC (collectively “UBS”) on February 1, 2008 1 for tortious interference with a business relationship arising out of the planned, but aborted, merger between Genesco, Inc. (“Genesco”) and The Finish Line, Inc. (“Finish Line”). Now before this court is UBS’s motion to dismiss pursuant to Federal Rules of Civil Procedure 12(b)(3), 12(b)(6), and 12(b)(7) 2 . For the *350 reasons set forth below, defendants’ motion is denied.

Background

The following facts are taken from plaintiffs complaint in this action (“Complaint”) and the parties’ papers submitted in connection with this motion. The facts alleged in the Complaint are presumed to be true for the purposes of the 12(b)(6) motion to dismiss.

Plaintiff is a resident of Brooklyn, New York, and a holder of Genesco common stock. Non-party Genesco, a Tennessee corporation that maintains its headquarters 3 in Nashville, Tennessee, is a retailer and wholesaler of branded footwear and a retailer of branded head wear. Genesco’s shares are traded on the New York Stock Exchange. Non-party Finish Line, an Indiana corporation that maintains its headquarters in Indianapolis, Indiana, is a large mall-based retailer of athletic apparel and shoes operating under the Finish Line, Man Alive, and Paiva brand names. Finish line’s shares are traded on the NASDAQ Global Select Market. Headwind, Inc. (“Headwind”) is a Tennessee corporation and wholly owned subsidiary of Finish Line formed for the sole purpose of completing a merger between Finish Line and Genesco.

Defendants UBS Securities LLC and UBS Loan Finance LLC are wholly owned subsidiaries of UBS AG and Delaware corporations with their principal places of business in New York. 4 UBS AG is a prominent investment banking and securities firm headquartered in Zurich, Switzerland.

On June 17, 2007, Finish Line entered into an Agreement and Plan of Merger (“Merger Agreement”) to acquire Genesco. UBS Securities LLC served as Finish Line’s financial advisor in connection with the merger and issued an opinion to Finish Line that the merger was fair from a financial point of view to Finish Line and its shareholders. Pursuant to the Merger Agreement, Finish Line was to pay $54.50 per share in cash for all the outstanding common stock of Genesco held by plaintiff and other members of the purported class. The merger was to be funded by $1.6 billion in debt financing from UBS. The Merger Agreement expressly stated that it conferred no rights upon any party as a third-party beneficiary. Further, pursuant to the Merger Agreement, if Genesco suffered a Material Adverse Effect, UBS would be excused from its obligations. Both the Merger Agreement and Commitment Letter, however, specifically excluded performance shortfalls due to industry-wide fluctuations from the definition of Material Adverse Effect. 5

*351 Finish Line and UBS executed a commitment letter (“Commitment Letter”) setting forth the terms of the financing on June 17, 2007. Also on June 17, 2007, Finish Line filed a Form 8-K 6 with the Securities and Exchange Commission (“SEC”), announcing the UBS commitment.

Genesco filed its proxy statement 7 with the SEC on July 11, 2007. On July 23, 2007, the SEC notified Genesco that it would not review the proxy statement and that Genesco could file and disseminate it. Shortly thereafter, Finish Line informed Genesco that it needed additional time to complete the UBS financing transaction.

On August 6, 2007, an article in the Indianapolis Business Journal reported that tightening of the credit markets along with a decline in Finish Line’s operating performance and stock price “spooked” UBS and that some analysts had begun speculating whether UBS would “pull the plug” on its financing commitment. The article further reported that Finish Line’s Chief Financial Officer, Kevin Wampler, stated during a June 29, 2007 conference call with analysts that neither Finish Line’s falling share price nor the tightening of the credit markets “give UBS an out” of its financing commitment.

On August 14, 2007, the necessary regulatory approvals for the merger were obtained. On August 30, 2007 Genesco issued a press release announcing its second quarter 2007 financials. Genesco’s earnings were lower than analysts’ estimates and reported a loss of $0.13 per share.

On September 11, 2007, UBS wrote to Finish Line that UBS was “extremely concerned” about the “apparent deteriorating financial position” of Genesco and that UBS was reserving its rights with respect to its obligation to complete the financing. The financial results announced by Genes-co on August 30, 2007, were consistent with results experienced by its peers, including Finish Line. 8 UBS had been re *352 eeiving weekly updates concerning Genes-co’s financial results.

On September 13, 2007, UBS wrote a second letter to Finish to report that UBS was “not yet satisfied that Genesco has not experienced a Material Adverse Effect.” On September 14, 2007, in response to this contention, Genesco issued a press release stating, “no ‘material adverse effect’ under the previously announced merger agreement with Finish Line has occurred with respect to Genesco.”

On September 17, 2007 Genesco’s shareholders, at a special shareholder meeting concerning the merger, approved the merger. Thus, as of September 17, 2007, Genesco had satisfied all of the pre-conditions to closing set forth in the Merger Agreement. Pursuant to the Merger Agreement, an obligation to close on or before September 19, 2007 was triggered.

On September 18, 2007, counsel for Finish Line e-mailed counsel for Genesco to advise Genesco that UBS decided to stop any further work towards closing the financing transaction “pending the results of its analyses of Genesco’s financial condition and performance.”

On September 19, 2007, Genesco issued a press release which contained a letter from its Chairman and Chief Executive Officer, Hal Pennington. Pennington stated Finish Line and UBS had failed to meet deadlines for obtaining the UBS financing needed to consummate the merger and set forth his belief that UBS was looking for a way out of its commitment because certain external factors, including upheaval in the credit markets, made the merger less profitable for UBS. 9

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
614 F. Supp. 2d 345, 2008 U.S. Dist. LEXIS 35462, 2008 WL 1968737, Counsel Stack Legal Research, https://law.counselstack.com/opinion/lasker-v-ubs-securities-llc-nyed-2008.